Krabbe disease also known as globoid cell leukodystrophy or galactosylceramide lipidosis is a rare, often fatal degenerative disorder that affects the myelin sheath of the nervous system. It is a form of sphingolipidosis, as it involves dysfunctional metabolism of sphingolipids. This condition is inherited in an autosomal recessive pattern. The disease is named after the Danish neurologist Knud Krabbe (1885–1965).
Illinois, Kentucky, and Pennsylvania have laws to test for Krabbe and other diseases at birth. There is a movement in Maine and other states to adopt such regulations.
Ohio Revised Code: 5.231 Krabbe Disease Awareness Week.
The second week of September is designated as "Krabbe Disease Awareness Week" to raise awareness of Krabbe disease, which is a life-threatening, inherited disorder that destroys the protective coating of nerve cells in the brain and nervous system, typically resulting in complications that include seizures, muscle spasms, muscle deterioration, blindness, deafness, and respiratory failure.
(Added by 131st General Assembly File No. TBD, HB 62, §1, eff. 10/15/2015.)
In 2023 Krabbe Disease Awareness Week in Ohio in USA falls on September 4.